Company Overview of CoDa Therapeutics, Inc.
CoDa Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapeutics for wound care, inflammation, and tissue repair based on a gap junction modulation in the United States and Europe. The company offers Nexagon, an oligonucleotide that downregulates the gap junction in tissue repair. Its Nexagon also reduces lesion spread, swelling, inflammation, scarring, and time to wound closure in various tissue types, including the eye, skin, spinal cord, nerve, and brain. The company was incorporated in 2005 and is based in San Diego, California.
12520 High Bluff Drive
San Diego, CA 92130
Founded in 2005
Key Executives for CoDa Therapeutics, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
June 13, 2016
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact CoDa Therapeutics, Inc., please visit www.codatherapeutics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.